Gamma-hydroxybutyrate (GHB) for prevention and treatment of alcohol withdrawal

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2006, Pages

  Leone, Maurizio A ^a   Avanzi, G C ^b   Lo Iacono, A ^b   Vigna Taglianti, F ^b   Faggiano, F ^b  

^a MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; PLACEBO;

AGITATION; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; CLINICAL TRIAL; COMA; CONFUSION; DEMOGRAPHY; DETOXIFICATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DIZZINESS; DRINKING BEHAVIOR; DRUG EFFICACY; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HALLUCINATION; HUMAN; HYPOTHERMIA; LENGTH OF STAY; NAUSEA; OUTCOME ASSESSMENT; RATING SCALE; RESPIRATORY TRACT DISEASE; REVIEW; SCORING SYSTEM; SIDE EFFECT; TREATMENT OUTCOME; UNCONSCIOUSNESS; VISUAL IMPAIRMENT; VOMITING; WEAKNESS;

EID: 37649031502     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006266     Document Type: Review

References (24)

1. Addolorato G, Cibin M, Capristo E, Beghè F, Gessa GL, Stefanini GF, et al. Maintaining abstinence from alcohol with gamma-hydroxybutyric acid. The Lancet 1998;351:38.
2. Agabio R, Colombo G, Loche A, Lobina C, Pani ML, Reali R, et al. Gamma-hydroxybutyric acid reducing effect on ethanol intake: evidence in favour of a substitution mechanism. Alcohol Alcohol 1998; 33:1-10.
3. Center for Disease Control and Prevention. Gamma-hydroxybutyrate use-New York and Texas, 1995-96. Morb Mortal Wkly Rep 1997;46:281-3.
4. Ceccanti M, Attilia ML, Blum K, Cavaleri G, Franzese A, Sasso GF, et al. Gamma-hydroxybutyric acid versus benzodiazepines: a clinical study in chronic alcoholics. Acta Toxicol Ther 1995;16:231-42.
5. Colombo G, Agabio R, Lobina C, Reali R, Fadda F, Gessa GL. Symmetrical generalization between tha discriminative stimulus effects of gamma-hydroxybutyric acid and ethanol: occurrence within narrow dose ranges. Physiol Behav 1995;57:105-11.
6. Colombo G, Agabio R, Diaz G, Reali R, Gessa GL. Gamma-hydroxybutyric acid (GHB) intake in ethanol-preferring (sP) and -nonpreferrig (sNP) rats. Physiol Behav 1998;64:197-202.
7. Di Bello MG, Gambassi F, Mugnai L, Masini E, Mannaioni PF. Gamma-hydroxybutyric acid induced suppression and prevention of alcohol withdrawal syndrome and relief of craving in alcohol dependent patients. Alcologia 1995;7:9-16.
8. American Psychiatric Association (Pub). Diagnostic and Statistical Manual of Mental Disorders. 4 edition. Washington DC:: American Psychiatric Association, 1994.
9. US Foood and Drug Administration. US Department of Health and Human Services, http://www.fda.gov/.
10. Frau M, Colombo G, Marchese G, Stefanini E, Gessa GL. Different affinity of cortical GHB binding site in sardinian alcohol-preferring (sP) and -nonpreferring (sNP) rats. Alcohol Alcohol 1995;30:133-7.
11. Gallimberti L, Canton G, Gentile N, Ferri M, Cibin M, Ferrara SD, et al. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal sindrome. The Lancet 1989;2:787-9.
12. Gallimberti L, Ferri M, Ferrara S, Fadda F, Gessa GL. Gamma-hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study. Alcoholism Clin Exp Res 1992;16:673-6.
13. Gessa GL, Agabio R, Carai M, Lobina C, Pani M, Reali R, et al. Mechanism of the anti-alcohol effect of gamma-hydroxybutyric acid (GHB). Alcohol 2000;20:271-6.
14. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ 2003;327:557-60.
15. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. The Cochrane Library 2006, issue 3.
16. Hillbom M, Pieninkeroinen I, Leone M. Seizures in Alcohol-Dependent Patients. Epidemiology, Pathophysiology and Management. CNS Drugs 2003;17:1013-30.
17. Moncini M, Masini E, Gambassi F, Mannaioni PF. Gamma-hydroxybutyric acid and alcohol-related syndromes. Alcohol 2000;20:285-95.
18. Morton A, Laird LK, Crane DF, Partovi N, Frye LH. A prediction model for identifying alcohol withdrawal seizures. Am J Drug Alcohol Abuse 1994;20:75-86.
19. Nimmerrichter AA, Walter H, Gutierrez-Lobos KE, Lesch OM. Double blind controlled trial of gamma-hydroxybutyrate and chlormethiazole in the treatment of alcohol withdrawal. Alcohol Alcohol 2002;37:67-73.
20. O'Connor PG, Schottenfeld RS. Patients with alcohol problems. N Engl J Med 1998;338:592-602.
21. Pieninkeroinen IP, Telakivi TM, Hillbom ME. Outcome in subjects with alcohol-provoked seizures. Alcohol Clin Exp Res 1992;16:955-9.
22. Schuckit MA. Alcoholism acute treatment. In: MASchuckit editor (s). Drug and alcohol abuse. A clinical guide to diagnosis and treatment. IV. New York-London: Plenum Medical Book Co, 1995:97-117.
23. Scottish Intercollegiate Guidelines Network. The management of harmful drinking and alcohol dependence in primary care. A national clinical guideline. www.sign.ac.uk 2003.
24. Tan CY, Weaver DF. Molecular pathogenesis of alcohol withdrawal seizures: the modified lipid-protein interaction mechanism. Seizure 1997;6:255-74.